InvestorCentral.us NEWSLETTER Members, * KALO * is our long-awaited Q3 Kick-off Play – get Ready to Lock and Load Tomorrow @ 9:30am EST! Symbol: KALO Current PPS: $0.136 <--- Outstanding Entry Point! 10-Day Avg Vol: 62.6K Outstanding Shares 142.8M Float 69.7M <--- Low Float! It`s been a little more than two-weeks since our last alert and we are most certainly itching for a Big Winner! Our expert analysts have spent that time digging through thousands of publicly traded companies in search of a Gem of True Unrealized Value! SL&L is positive that we found our Next Huge Gainer in * KALO * with the potential to change the future of the $4.5 Billion Healthcare sector forever! Kallo Inc. (KALO) is a 2006 founded medical technology and information company based in Markham, Canada, that engages in the manufacturing and development of a software solution that aids physicians and nurses in streamline the mass of patient information in a coherent and usable manner that will reduce the cost of providing medical care, while also dramatically improving the quality and efficiency of healthcare services offered by healthcare institutions.
KALOs technology stores all medical information, including pharmaceutical, laboratory and diagnostic systems, into a single-source Electronic Medical Record (EMR); allowing healthcare service providers real-time access to an individuals complete medical information.
KALOs medical device connectivity (MDC) will connect any medical device to any clinical application and integrate with the existing technologies already in place. KALOs MDC will automatically update the EMRs, which in turn, will reduce charting errors, recover medical staff time and improve workflow.
Additionally, KALO has developed a cloud-based device agnostic Picture Archival and Communication System (PACS) that permits immediate, on demand transfer and recovery of patient images, such as X-rays, ultrasound, MRI scans and other needed images; across a global platform.
KALOs EMR, PACS, and MDC technology has U.S. and Canada licensing rights to be distributed across both nations. As a result, KALOs client base currently consists of 6,700 installed units and has maintained a 100% retention rate since KALOs inception.
Furthermore, KALO has recently developed a mobile clinic, or telehealth technology, known as Mc-Telehealth which consists of Mobile Clinics, Clinical and Admin. Command Centers along with KALOs top of the line medical devices and medication information and connectivity solutions.
KALOs newest development has received overwhelming responses from 24 countries that have begun discussions with KALO on adopting its new Mobile Care Technology.
www.kalloinc.ca Just about two-months ago, * KALO * was trading as High as $0.30! SL&L expects a return run to that level, which would put as much as +120.59% profit in our members pockets! Make sure you check out KALO`s 3-month chart below, and read the company`s most recent press release that follows…
And, ofcourse remember to check your email Tomorrow morning! SL&L will be releasing it`s FULL REPORT on KALO!! KALO Announces Distribution Areas 8:00a ET June 29, 2012 (PR NewsWire) Kallo, Inc. (OTCQB: KALO) is pleased to announce that they are currently licensed to distribute their Electronic Medical Record (EMR) systems, Picture Archiving and Communication System (PACS), and Medical Device Connectivity System (MDC) throughout The United States and Canada. Kallo, Inc. is currently the only company in this sector customizing its systems to individual practices, offering the flexibility needed to set these practices apart from the competition.
“The 2008 US Stimulus goal of utilization of an electronic health record for each person in the United States by 2014 is rapidly approaching and Kallo.
is excited to be able to offer our products in the US to assist physicians in meeting the EMR requirements.” “The United States and Canada are responsible for approximately 50% of the global IT expenditures in the healthcare sector. We are positioned to increase our presence and distribution in the marketplace,” stated John Cecil, Chairman and CEO.
Kallo, Inc. is currently negotiating distribution in 24 countries.
Kallo OEM currently has a client base of 6700 units installed and has maintained a 100 percent retention rate over the last 7 years of operations.
ABOUT Kallo, Inc., a medical information company, engages in the manufacturing and development of software that assists physicians and nurses to streamline patient information. Its software solution includes Electronic Medical Record software (EMR) and connectivity software that gathers medical information from various sources and deposits it into a single source as an electronic medical record for each patient.
Kallo, Inc. is a publicly traded company, listed on the OTC markets, (otcmarkets.com) stock symbol KALO.OB Media contact: John Cecil or Vince Leitao 416-246-9997 http://www.kalloinc.ca SOURCE Kallo Inc.
—————————————————————————————- Follow SL&L on:
 *To make sure you receive email alerts, please add alerts@InvestorCentral.us to your email`s contact list.
This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: InvestorCentral.us and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
InvestorCentral.us does not provide trading, investment or tax advice, and readers shall not rely on statements by InvestorCentral.us employees which purport to provide such advice. Full disclaimer can be read at:
Release of Liability: Through use of this website viewing or using you agree to hold InvestorCentral.us, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. InvestorCentral.us encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and InvestorCentral.us makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead InvestorCentral.us strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
InvestorCentral.us is compliant with the Can Spam Act of 2003.
InvestorCentral.us does not offer such advice or analysis, and InvestorCentral.us further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk.
It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.
InvestorCentral.us has been compensated twenty thousand dollars for this one-day profile on KALO by Equities Awareness Group, LLC.
InvestorCentral.us owns no shares of KALO or any other company aforementioned in this email, nor plans on buying any in the future. The third party may have shares and may liquidate it which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.
All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1 9 3 3 Securities Act.
Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies.
InvestorCentral.us has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisement should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact the share price of the profiled company negatively. InvestorCentral.us affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.
The Private Securities Litigation Reform Act of 1995 provides investors a `safe harbor` in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”.
Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur.
Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, InvestorCentral.us has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, InvestorCentral.us and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement.
InvestorCentral.us is not responsible for any claims made by the companies advertised herein, nor is InvestorCentral.us responsible for any other promotional firm, its program or its structure.
———————————————————————————————————————-——————————————————Investor Central 2012 References 1. http://www.InvestorCentral.us/
2. http://www.otcmarkets.com/stock/KALO/company-info 3. http://www.twitter.com/Stockswager 4. http://www.facebook.com/pages/StockLockandLoadcom/193974263971920 5. mailto:alerts@InvestorCentral.us 6. http://www.InvestorCentral.us/disclaimer/
This message was sent to from:
MJ Capital, LLC | 110 Main Street | Newark, nj 07102
See Investor Central’s website for full disclaimer. Investor Central may have received compensation for stock picks.